Literature DB >> 24173679

Regulation of major vault protein expression by upstream stimulating factor 1 in SW620 human colon cancer cells.

Ryuji Ikeda1, Yukihiko Nishizawa, Yusuke Tajitsu, Kentaro Minami, Hironori Mataki, Shogo Masuda, Tatsuhiko Furukawa, Shin-Ichi Akiyama, Katsushi Yamada, Yasuo Takeda.   

Abstract

Major vault protein (MVP) is the main constituent of the vault ribonucleoprotein particle and is identical to lung resistance-related protein (LRP). Although MVP is also expressed in several types of normal tissues, little is known about its physiological role. In the present study, we identified the crucial MVP promoter elements that regulate MVP expression. An examination of tissue expression profiles revealed that MVP was expressed in the heart, placenta, lung, liver, kidney and pancreas. Elements of the MVP promoter contain binding sites for transcription factors, STAT, p53, Sp1, E-box, GATA, MyoD and Y-box. By deletion analysis, a conserved proximal E-box binding site was demonstrated to be important for human MVP promoter transactivation. Introduction of siRNA against upstream stimulating factor (USF) 1, which is known to bind the E-box binding site, decreased the expression of MVP in SW620 and ACHN cells. Using a chromatin immunoprecipitation (ChIP) assay, USF1 bound the MVP promoter in SW620 cells. These findings suggest that USF1 binding to an E-box element may be critical for basal MVP promoter activation. The results of the present study are useful in understanding the molecular mechanisms regulating MVP gene expression, and may aid in elucidating the physiological functions of MVP.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24173679     DOI: 10.3892/or.2013.2818

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  8 in total

1.  Significant association between upstream transcription factor 1 rs2516839 polymorphism and hepatocellular carcinoma risk: a case-control study.

Authors:  Xiaodong Zhao; Tianyi Wang; Bo Liu; Zhenzhou Wu; Shuo Yu; Tao Wang
Journal:  Tumour Biol       Date:  2014-12-06

2.  Whole genome expression profiling shows that BRG1 transcriptionally regulates UV inducible genes and other novel targets in human cells.

Authors:  Ling Zhang; Leah Nemzow; Hua Chen; Jennifer J Hu; Feng Gong
Journal:  PLoS One       Date:  2014-08-26       Impact factor: 3.240

3.  Integrative genomic analyses of a novel cytokine, interleukin-34 and its potential role in cancer prediction.

Authors:  Bo Wang; Wenming Xu; Miaolian Tan; Yan Xiao; Haiwei Yang; Tian-Song Xia
Journal:  Int J Mol Med       Date:  2014-11-12       Impact factor: 4.101

4.  Suppression of metastasis through inhibition of chitinase 3-like 1 expression by miR-125a-3p-mediated up-regulation of USF1.

Authors:  Ki Cheon Kim; Jaesuk Yun; Dong Ju Son; Ji Young Kim; Jae-Kyung Jung; Jeong Soon Choi; Yu Ri Kim; Ju Kyung Song; Sun Young Kim; Sin Kook Kang; Dae Hwan Shin; Yoon-Seok Roh; Sang-Bae Han; Jin Tae Hong
Journal:  Theranostics       Date:  2018-08-07       Impact factor: 11.556

Review 5.  The Vault Nanoparticle: A Gigantic Ribonucleoprotein Assembly Involved in Diverse Physiological and Pathological Phenomena and an Ideal Nanovector for Drug Delivery and Therapy.

Authors:  Gianni Frascotti; Elisabetta Galbiati; Matteo Mazzucchelli; Maria Pozzi; Lucia Salvioni; Jacopo Vertemara; Paolo Tortora
Journal:  Cancers (Basel)       Date:  2021-02-09       Impact factor: 6.639

6.  USF1 Transcriptionally Regulates UGT1A3 and Promotes Lung Adenocarcinoma Progression by Regulating Neurotrophin Signaling Pathway.

Authors:  Yu Wang; Yun-Xia Zhao; Xiang-Wei Zhang; Yuan-Zhu Jiang; Wei Ma; Lin Zhang; Wei Dong
Journal:  Front Mol Biosci       Date:  2022-01-27

7.  A dual role of human tRNA methyltransferase hTrmt13 in regulating translation and transcription.

Authors:  Hao Li; Han Dong; Beisi Xu; Qing-Ping Xiong; Cai-Tao Li; Wen-Qing Yang; Jing Li; Zhi-Xuan Huang; Qi-Yu Zeng; En-Duo Wang; Ru-Juan Liu
Journal:  EMBO J       Date:  2021-12-01       Impact factor: 11.598

8.  miR-210-3p Promotes Lung Cancer Development and Progression by Modulating USF1 and PCGF3.

Authors:  Qian Chen; Hongyu Zhang; Jianyin Zhang; Le Shen; Jing Yang; Yan Wang; JinXiu Ma; Bing Zhuan
Journal:  Onco Targets Ther       Date:  2021-06-09       Impact factor: 4.147

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.